Arkolith/Insider Trading/BCAX/Form 4

Cohlhepp Ryan

President and COO, DirectorBicara Therapeutics Inc. (BCAX) · full profile →Form 4 · filed May 18, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$254K
Net Open-Market Flow
-$254K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 15, 2026Option exercise(M)8K$3.79$30K204K
May 15, 2026Sell(S)8K$20.29$162K196K
May 15, 2026Sell(S)5K$20.29$91K192K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 15, 2026Option exercise(M)8K—$0101K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-035937) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML